Try our Advanced Search for more refined results
Arbutus Biopharma Corp.
-
Misc | Filed: June 10, 2024 | Entered: June 10, 2024 Arbutus Biopharma Corporation et al v. Moderna, Inc. et al
Patent | Delaware
Request for Oral Argument
REQUEST for Oral Argument by Arbutus Biopharma Corporation, Genevant Sciences GmbH. (Hoeschen, Nathan)
-
Misc | Filed: June 10, 2024 | Entered: June 10, 2024 Arbutus Biopharma Corporation et al v. Moderna, Inc. et al
Patent | Delaware
Letter
[SEALED] Letter to The Honorable Mitchell S. Goldberg from Brian P. Egan regarding Opposition to Plaintiffs' Motion to Compel (D.I. 313) - re 313 Opening Brief in Support,. (Attachments: # 1 Ex A - 03/13/24 Email from Lachman to Y. Li re Interrogatory 18, # 2 Ex. B - 04/10/24 Letter from M. Lachman to Y. Li re ROG No. 18, # 3 Ex. C - 04/19/24 Letter to Lachman re Interrogatory 18)(Egan, Brian)
-
Misc | Filed: June 10, 2024 | Entered: June 10, 2024 Arbutus Biopharma Corporation et al v. Moderna, Inc. et al
Patent | Delaware
Redacted Document
REDACTED VERSION of 321 Answer to Amended Complaint, Counterclaim by Moderna, Inc., ModernaTX, Inc.. (Murray, Travis)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login